Getting a plaque psoriasis diagnosis is straightforward. Your healthcare provider takes your medical history and inquires about symptoms and overall health. They may also want to know if you’re under ...
Psoriasis is a skin condition that involves an itchy, scaly rash. It is caused by the immune system attacking healthy cells, which speeds up skin cell growth and leads to a buildup of dead cells on ...
The PASI score relates to the amount of surface area on each part of the body that is covered by psoriasis plaques and also grades severity of the plaques. A score of 90 or more means that this has ...
Icotrokinra’s ability to be administered orally is one of its most notable advantages. For patients with moderate-to-severe plaque psoriasis, the prospect of a once-daily pill could represent a major ...
Positive, phase 3 data for once-daily JNJ-2113 (icotrokinra) has been announced by Protagonist Therapeutics in collaboration with Johnson & Johnson that demonstrated "significant" skin clearance ...
Tremfya (guselkumab) is a prescription drug that’s used to treat certain inflammatory conditions, such as plaque psoriasis. The drug is available as an injection given under the skin or as an IV ...
The following medications are indicated for plaque psoriasis, unless otherwise specified. Impoyz 0.025% crm Adults: Apply twice daily; max 50g/week and 2 consecutive weeks’ treatment per course.